WorryFree Computers   »   [go: up one dir, main page]
  • COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Visual outcomes of small-aperture IOL implant in post-laser refractive eyes

Video
Conferences|AAO

Robert Ang, MD, discusses highlights of his AAO 2020 presentation on a study analyzing the vIsual outcomes of a small-aperture IOL implantation in patients with a history of post-laser refractive surgery.


Robert Ang, MD, director, Refractive Surgery Department, Asian Eye Institute (Philippines), discusses highlights of his AAO 2020 presentation on a study titled, "Visual outcomes of small-aperture IOL implantation in post-laser refractive eyes."

See more AAO coverage

Related Videos
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s futureEyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to OphthalmologyEyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Video 3 - "Approaching Asymptomatic Cases with Risk Factors"Video 3 - "Approaching Asymptomatic Cases with Risk Factors"
Video 2 - "Do Dry Eye Diagnostics Change the Management of Dry Eye?"Video 2 - "Do Dry Eye Diagnostics Change the Management of Dry Eye?"
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual MeetingsDr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Deb Ristvedt, DO's CIME 2024 Talk Highlights Innovations in Treating Glaucoma via the Trabecular MeshworkDeb Ristvedt, DO's CIME 2024 Talk Highlights Innovations in Treating Glaucoma via the Trabecular Meshwork
Dr. Inder Paul Singh's Insights: Improving Glaucoma Outcomes with Early Intervention and Reduced MedicationDr. Inder Paul Singh's Insights: Improving Glaucoma Outcomes with Early Intervention and Reduced Medication
CIME 2024: Kelsey Roelofs, MD, details collaborative strategies for the management of thyroid eye diseaseCIME 2024: Kelsey Roelofs, MD, details collaborative strategies for the management of thyroid eye disease
Related Content
Data and Safety Monitoring Board approves simultaneous enrollment in Cohort 3 and Phase 2 initiation in OCU410 ArMaDa study for GAData and Safety Monitoring Board approves simultaneous enrollment in Cohort 3 and Phase 2 initiation in OCU410 ArMaDa study for GA

Data and Safety Monitoring Board approves simultaneous enrollment in Cohort 3 and Phase 2 initiation in OCU410 ArMaDa study for GA

Article
Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary VenturesEhsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

(EyePod) From idea to impact: Navigating ophthalmic innovation

Podcast
FDA qualifies Assessment of IntraOcular Lens Implant Symptoms (AIOLIS) as Medical Device Development ToolFDA qualifies Assessment of IntraOcular Lens Implant Symptoms (AIOLIS) as Medical Device Development Tool

FDA qualifies Assessment of IntraOcular Lens Implant Symptoms (AIOLIS) as Medical Device Development Tool

Article
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgeryEyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery

EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery

Podcast
Prevent Blindness kicks off ‘It Started With an Eye Exam’Prevent Blindness kicks off ‘It Started With an Eye Exam’

Prevent Blindness kicks off ‘It Started With an Eye Exam’

Article
Alcon to acquire Belkin Vision in deal estimated at $335 millionAlcon to acquire Belkin Vision in deal estimated at $335 million

Alcon to acquire Belkin Vision in deal estimated at $335 million

Article
© 2024 MJH Life Sciences

All rights reserved.